These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33587395)

  • 1. Does a Positive Response to Lithium Augmentation in Resistant Major Depression Indicate a Bipolar Disorder?: A Long-Term Follow-up Study.
    Birkenhager TK; Shapiro-Koss C; Kamperman AM
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):202-204. PubMed ID: 33587395
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium in the treatment of major depressive disorder.
    Bschor T
    Drugs; 2014 Jun; 74(8):855-62. PubMed ID: 24825489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
    Kok RM; Vink D; Heeren TJ; Nolen WA
    J Clin Psychiatry; 2007 Aug; 68(8):1177-85. PubMed ID: 17854241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of an Optimal Dose of Lamotrigine for Augmentation Therapy in Treatment-Resistant Depressive Disorder From Plasma Lamotrigine Concentration at Week 2.
    Nakamura A; Mihara K; Nagai G; Kagawa S; Suzuki T; Nemoto K; Kondo T
    Ther Drug Monit; 2016 Jun; 38(3):379-82. PubMed ID: 26829597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.
    Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy.
    Berger M; Kermer J; Behr J; Schulz-Menger J; Bilal S; Osterland SL; O'Malley G; Bschor T; Schlattmann P; Stamm T; Steinacher B; de Millas W; Richter C; Heinz A; Adli M; Buspavanich P; Ricken R
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):87-91. PubMed ID: 34854829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.
    Wang JCC; Swainson J
    J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium treatment for unipolar major depressive disorder: Systematic review.
    Undurraga J; Sim K; Tondo L; Gorodischer A; Azua E; Tay KH; Tan D; Baldessarini RJ
    J Psychopharmacol; 2019 Feb; 33(2):167-176. PubMed ID: 30698058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
    Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
    J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.
    Inoue T; Abekawa T; Nakagawa S; Suzuki K; Tanaka T; Kitaichi Y; Boku S; Nakato Y; Toda H; Koyama T
    J Affect Disord; 2011 Mar; 129(1-3):64-7. PubMed ID: 20837361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M; Adli M; Baethge C; Berghöfer A; Sasse J; Heinz A; Bschor T
    Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
    Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisaccades as a follow-up tool in major depressive disorder therapies: a pilot study.
    Malsert J; Guyader N; Chauvin A; Polosan M; Poulet E; Szekely D; Bougerol T; Marendaz C
    Psychiatry Res; 2012 Dec; 200(2-3):1051-3. PubMed ID: 22648007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
    Fawcett J; Rush AJ; Vukelich J; Diaz SH; Dunklee L; Romo P; Yarns BC; Escalona R
    Am J Psychiatry; 2016 Feb; 173(2):107-11. PubMed ID: 26844792
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
    Marwood L; Taylor R; Goldsmith K; Romeo R; Holland R; Pickles A; Hutchinson J; Dietch D; Cipriani A; Nair R; Attenburrow MJ; Young AH; Geddes J; McAllister-Williams RH; Cleare AJ
    BMC Psychiatry; 2017 Jun; 17(1):231. PubMed ID: 28651526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of efficacy in lithium augmentation for treatment-resistant depression.
    Sugawara H; Sakamoto K; Harada T; Ishigooka J
    J Affect Disord; 2010 Sep; 125(1-3):165-8. PubMed ID: 20089312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.